bf/NASDAQ:GLUE_icon.jpeg

COM:MONTEROSATX

Monte Rosa Therapeutics

  • Stock

Last Close

8.84

05/11 21:00

Market Cap

238.49M

Beta: -

Volume Today

683.62K

Avg: -

Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing protein for the treatment of Myc-driv...Show More

investor of